Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...